Pancreatic Cancer Research

ResearcherParacelsus Medical UniversityNo recent work listed

Gabriel Rinnerthaler

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7438-1465; OpenAlex author ID A5082631402. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: 1 paper

Papers 3

  1. Overcoming negative predictions of microRNA expressions to gemcitabine response with FOLFIRINOX in advanced pancreatic cancer patients. Last author DOI 10.2144/fsoa-2020-0128↗
  2. Nonmetastatic pancreatic cancer : Improved survival with chemoradiotherapy > 40 Gy after systemic treatment. Co-author DOI 10.1007/s00066-018-1281-7↗
  3. Female gender may predict response to FOLFIRINOX in patients with unresectable pancreatic cancer: a single institution retrospective review. Co-author DOI 10.3892/ijo.2013.2176↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Richard Greil · 3 shared papers, 2014–2020 · strength 0.21
  2. Florian Hohla · 2 shared papers, 2014–2020 · strength 0.14
  3. Stefan Stättner · 2 shared papers, 2014–2020 · strength 0.14
  4. Konstantin Schlick · 1 shared paper, 2020 · strength 0.10
  5. Sebastian Bachmayer · 1 shared paper, 2018 · strength 0.07
  6. Franz Zehentmayr · 1 shared paper, 2018 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.